Urolithin A and Hearing Health: What the Early Research Shows
Key takeaways
- Age-related hearing change (presbycusis) is very common and is driven partly by oxidative stress and mitochondrial decline in the inner ear.
- Damaged mitochondria accumulate in cochlear cells with age; preclinical work links failing mitophagy to faster aging of hearing cells. (PRECLINICAL)
- In lab auditory cells and aging mice, standardized Urolithin A activated mitophagy and lowered cellular-senescence markers in inner-ear tissue. (PRECLINICAL)
- There are no human trials of Urolithin A for hearing; the human evidence so far is in muscle and mitochondrial biomarkers. (HUMAN)
- Protecting hearing is still mostly about the basics — noise protection and cardiovascular health — with cellular support as a complement, never a cure.
Why does hearing change with age?
Age-related hearing loss, known medically as presbycusis, is one of the most common conditions of later life, affecting a large share of adults over 65. (reference) It usually comes on gradually, often starting with higher-pitched sounds and with difficulty following conversation in noisy rooms. The causes are a mix: a lifetime of noise exposure, genetics, blood-vessel and metabolic health, certain medications, and the simple biology of aging tissue.
At the center of the ear is the cochlea, a fluid-filled spiral lined with sensory hair cells that convert sound vibrations into nerve signals. These hair cells and their supporting cells are metabolically demanding and, in mammals, largely cannot regenerate once lost. That combination — high energy needs plus no replacement — is why researchers studying the mechanics of hearing loss keep coming back to one organelle in particular: the mitochondrion. A long line of work points to oxidative stress and mitochondrial decline as central drivers of the aging cochlea. (review)
What do mitochondria have to do with hearing?
Hearing is an energy-hungry process. The hair cells and the stria vascularis (the structure that maintains the cochlea's electrical environment) burn a lot of ATP, and that work is done by mitochondria. Over time, mitochondria accumulate damage and produce more reactive oxygen species, and the cell's ability to clear the worn-out ones — mitophagy — tends to slip.
Preclinical research has tied that slippage directly to hearing-cell aging. In one study, blocking a key mitophagy pathway (DRP-1-dependent mitophagy) pushed cochlear hair cells toward senescence and worsened age-related hearing loss in a model system. (preclinical) The takeaway from that line of work is intuitive: when the inner ear cannot keep its mitochondria clean, its cells age faster. That is the exact process standardized Urolithin A has been studied for — in other tissues — which is why scientists have begun testing it in the ear. (PRECLINICAL)
What does the research on Urolithin A and hearing actually show?
Two kinds of early studies stand out, and it is worth being precise about what each one is.
Laboratory auditory cells
In cultured auditory cells pushed into premature aging, standardized Urolithin A activated mitophagy and attenuated the cells' senescence — essentially helping the cells clear damaged mitochondria and hold off some markers of cellular aging. (preclinical, Scientific Reports 2022) This is a petri-dish result: encouraging mechanistically, but a long way from a person's hearing. (PRECLINICAL)
Aging mice
A 2024 study reported that Urolithin A helped prevent age-related hearing decline in a strain of mice prone to it, apparently by inducing mitophagy in the inner ear. (preclinical, Hearing Research 2024) An animal result is a step up from cells in a dish, but mice are not people, the doses and delivery differ, and a single model strain cannot tell us how humans would respond. (PRECLINICAL)
| Study type | Model | What was observed | Evidence grade |
|---|---|---|---|
| Cell culture | Auditory (inner-ear) cells | Urolithin A activated mitophagy and reduced senescence markers | Preclinical |
| Animal | Aging-prone mice | Less age-related hearing decline, linked to inner-ear mitophagy | Preclinical |
| Mechanism | Cochlear hair cells | Blocking mitophagy sped hearing-cell senescence | Preclinical |
| Human | — | No hearing trials; human data is in muscle/mitochondrial markers | Not yet studied |
What this does — and does not — mean for you
It means the mechanism is plausible and scientifically interesting. The inner ear ages in large part through mitochondrial decline, mitophagy is central to keeping mitochondria healthy, and standardized Urolithin A is one of the better-characterized dietary mitophagy activators — with human trials in muscle showing it can engage mitochondrial biology in people. (preclinical, Nature Medicine 2016) (human RCT, Cell Reports Medicine 2022)
It does not mean Urolithin A prevents, treats, or reverses hearing loss. There are no human hearing studies, full stop. Anyone claiming a supplement protects or restores your hearing is ahead of the evidence. The accurate way to think about Urolithin A here is as general cellular-health support that happens to act on a pathway the inner ear relies on — not as anything aimed at a hearing condition. For people who want a consistent daily dose while that research matures, SOMA Urolithin A gummies provide a standardized 1,000 mg serving.
How to protect your hearing (what actually has evidence)
The highest-value steps are well established and have nothing to do with supplements. Limit loud-noise exposure and use hearing protection around power tools, concerts, and machinery; noise damage is cumulative and permanent. Keep the volume down on earbuds and give your ears quiet breaks. Tend to cardiovascular and metabolic health, since the cochlea depends on good blood flow. Review ototoxic medications with a clinician if you take them long-term. And get hearing checked if you notice changes, because early support (including hearing aids when appropriate) makes a real difference to quality of life. Cellular-health habits, including a mitophagy-support ingredient, sit on top of these fundamentals — they do not replace them.
Frequently asked questions
Does Urolithin A improve hearing?
There is no human evidence that it improves or protects hearing. The supportive findings are in cultured cells and mice, which cannot be extended to people's hearing.
Why is Urolithin A being studied for the ear at all?
Because the inner ear ages partly through mitochondrial decline, and Urolithin A is a well-characterized mitophagy activator. The biology lines up; the human proof does not exist yet.
Is the muscle research relevant to hearing?
Only indirectly. Human muscle trials show Urolithin A can engage mitochondrial biology in people, which is why researchers find the ear plausible — but muscle data cannot stand in for hearing data.
Can Urolithin A undo noise damage?
No. Noise-related hair-cell loss is generally permanent, and no supplement reverses it. Prevention through hearing protection is the only reliable approach.
Should I take Urolithin A for my ears?
Not as a hearing treatment. Some people take standardized Urolithin A for general cellular-health support; if your concern is hearing specifically, see an audiologist and focus on the evidence-based steps above.
Support your cellular health, every day
SOMA delivers a high-potency 1,000 mg dose of Urolithin A in one simple daily gummy — no guesswork, no converter-status lottery.
Shop SOMA Urolithin A Gummies →These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.